Skip to content
GenoLensGenoLens

GTPBP1

Chr 22q13.1

GTP binding protein 1

Aliases:
GP-1, HSPC018
MANE:
ENST00000216044.10

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1

    0.54
  • neurodegenerative disease

    0.33
  • prostate carcinoma

    0.30
  • Emery-Dreifuss muscular dystrophy

    0.19
  • disorder of ear

    0.18
  • cholelithiasis

    0.15
  • diverticular disease

    0.06
  • chronic kidney disease

    0.05
  • nonpapillary renal cell carcinoma

    0.04
  • infection

    0.04

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

GTP-binding protein 1

GTPase that plays a role in the elongation phase of protein synthesis by forming ternary complexes with GTP and aminoacyl-transfer RNAs (aa-tRNAs), and delivering aa-tRNAs to the ribosomal A site in a GTP-dependent manner (PubMed:30108131). Is also able to deliver deacylated tRNA to the A site (PubMed:30108131). Additionally, it is involved in RNA quality control; after GTP hydrolysis, which is not immediately followed by rapid peptide bond formation, GTPBP1 likely retains aa-tRNA in the A site and promotes exosomal degradation of faulty mRNAs engaged in 80S elongation complexes (PubMed:30108131). Plays a role in the regulation of circadian mRNA stability (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.